These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31627757)

  • 1. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018.
    Song WM; Li YF; Ma XB; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; Yu CB; Gao L; Cui LL; Li HC
    Respir Res; 2019 Oct; 20(1):223. PubMed ID: 31627757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.
    He XC; Zhang XX; Zhao JN; Liu Y; Yu CB; Yang GR; Li HC
    Medicine (Baltimore); 2016 Apr; 95(15):e3336. PubMed ID: 27082586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020.
    Song WM; Li SJ; Liu JY; Fu Q; Xu TT; Tao NN; Zhang QY; Liu SQ; An QQ; Zhu XH; Liu Y; Yu CB; Li YF; Dong J; Li HC
    BMJ Open; 2022 Jul; 12(7):e059149. PubMed ID: 35902191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of epidemiological characteristics of extrapulmonary tuberculosis from South-Central China.
    Yu Y; Xiang Y; Liu H; Yang S; Li M; Liu B; Xu D; Wu Y; Li W; Fang T; Li J; Xu D; Wan K; Tan Y; Yuan X; Li G
    Front Public Health; 2024; 12():1405358. PubMed ID: 39086797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
    Pan Y; Yu Y; Yi Y; Dou X; Lu J; Zhou L
    BMC Infect Dis; 2023 Mar; 23(1):162. PubMed ID: 36922787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019.
    An Q; Song W; Liu J; Tao N; Liu Y; Zhang Q; Xu T; Li S; Liu S; Li Y; Yu C; Li H
    Infect Drug Resist; 2020; 13():4133-4145. PubMed ID: 33223840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019.
    Song WM; Guo J; Xu TT; Li SJ; Liu JY; Tao NN; Liu Y; Zhang QY; Liu SQ; An QQ; Li YF; Yu CB; Dong JH; Li HC
    BMC Pulm Med; 2021 Dec; 21(1):399. PubMed ID: 34872558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis.
    Cai X; Xu X; He G; Jiang X; Wu L
    BMC Infect Dis; 2024 Aug; 24(1):807. PubMed ID: 39123148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
    Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
    Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004-2019.
    Tao NN; Li YF; Song WM; Liu JY; Zhang QY; Xu TT; Li SJ; An QQ; Liu SQ; Li HC
    BMJ Open; 2021 Jun; 11(6):e044349. PubMed ID: 34135033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
    Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
    PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of drug-resistant Mycobacterium tuberculosis in Hainan Island, China.
    Lin M; Zhong Y; Chen Z; Lin C; Pei H; Shu W; Pang Y
    Trop Med Int Health; 2019 Sep; 24(9):1098-1103. PubMed ID: 31278806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and trends of primary drug-resistant tuberculosis in Chongqing, China, from 2012 to 2020.
    Zhang H; Yang J; Zhang Z; Hu K; Wu P; Zhang H; Li J; Li M; Wang X
    Medicine (Baltimore); 2023 Mar; 102(10):e33230. PubMed ID: 36897690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
    Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
    Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis on epidemiological and drug resistance characteristics of lymph node tuberculosis from Hunan province, China.
    Fang T; Xiang Y; Li W; Liu B; Liu H; Wu Y; Xu D; Li M; Yang S; Li J; Yu Y; Zhao X; Zhao LL; Wan K; Yuan X; Tan Y; Li G
    Front Public Health; 2024; 12():1432065. PubMed ID: 39035178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
    Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z
    PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
    Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y
    BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya.
    Ombura IP; Onyango N; Odera S; Mutua F; Nyagol J
    PLoS One; 2016; 11(10):e0163994. PubMed ID: 27711122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.